PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Used as a traditional remedy for gastrointestinal ailments and dyspepsia [PMID:38337986, 26074998].
Extracts inhibited adipocyte differentiation in 3T3-L1 cells and reduced weight gain in high-fat-diet-induced mouse models [PMID:32466183].
Root extracts showed inhibitory activity against aldose reductase (ALR2) and dose-dependently inhibited sorbitol accumulation in human erythrocytes [PMID:22844269].
In vitro and in vivo (mice) studies showed that G. lutea extract, especially in combination with Prunella vulgaris, inhibited COX2 mRNA expression and catabolic factors [PMID:36670908].
Extracts from root and shoot demonstrated UV-protective and antigenotoxic properties in human fibroblast and melanoma cells [PMID:35253882].
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 32469702 (2021) — Effects of Gentiana lutea Root on Vascular Diseases. · Current vascular pharmacology
- 2.PMID: 36423749 (2023) — The healing bitterness of Gentiana lutea L., phytochemistry and biological activities: A systematic review. · Phytochemistry
- 3.PMID: 31538881 (2019) — Potential of Gentiana lutea for the Treatment of Obesity-associated Diseases. · Current pharmaceutical design
- 4.PMID: 26074998 (2015) — Bitters: Time for a New Paradigm. · Evidence-based complementary and alternative medicine : eCAM
- 5.PMID: 36001997 (2022) — Leaves of Yellow Gentian (Gentiana lutea) as an Alternative Source of Bitter Secoiridoid Glycosides.